Cargando…
Efficacy of mRNA and Inactivated Whole Virus Vaccines Against COVID-19 in Patients with Chronic Respiratory Diseases
BACKGROUND: While different COVID-19 vaccines have been developed, there has been lack of data on the efficacy comparison between mRNA and inactivated whole virus vaccine among patients with chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and bronchiecta...
Autores principales: | Kwok, Wang Chun, Leung, Sze Him Isaac, Tam, Terence Chi Chun, Ho, James Chung Man, Lam, David Chi-Leung, Ip, Mary Sau Man, Ho, Pak Leung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869785/ https://www.ncbi.nlm.nih.gov/pubmed/36698687 http://dx.doi.org/10.2147/COPD.S394101 |
Ejemplares similares
-
Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting
por: Kwok, Wang Chun, et al.
Publicado: (2023) -
Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications
por: Kwok, Wang Chun, et al.
Publicado: (2021) -
Serum protein level as a predictor of therapeutic response and adverse effects associated with afatinib use
por: Kwok, Wang Chun, et al.
Publicado: (2022) -
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common
EGFR
mutation in first‐line setting
por: Kwok, Wang Chun, et al.
Publicado: (2022) -
Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
por: Kwok, Wang Chun, et al.
Publicado: (2023)